[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336615-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336615-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","correspondence-a-commentary-on-assessment-of-treatment-outcomes-cytoreductive-surgery-compared-to-radiotherapy-in-oligometastatic-prostate-cancer","Correspondence - A commentary on 'Assessment of treatment outcomes: cytoreductive surgery compared to radiotherapy in oligometastatic prostate cancer'","","Letter to the editor providing a critical commentary on a pooled analysis comparing cytoreductive surgery versus radiotherapy for oligometastatic prostate cancer. The authors commend reported improvements in cancer-specific and overall survival, but raise concerns about inconsistent survival data versus primary study results, unclear sourcing of PFS and CRPCFS data, possible incorrect extraction of sample size, implausible negative hazard ratios in forest plots, and a misspelling of “radiotherapy” that may affect retrieval.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/correspondence-a-commentary-on-assessment-of-treatment-outcomes-cytoreductive-surgery-compared-to-radiotherapy-in-oligometastatic-prostate-cancer/336615/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/correspondence-a-commentary-on-assessment-of-treatment-outcomes-cytoreductive-surgery-compared-to-radiotherapy-in-oligometastatic-prostate-cancer/336615.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of this correspondence letter?","Question",{"text":63,"@type":64},"To comment on a study comparing cytoreductive surgery with radiotherapy for oligometastatic prostate cancer, highlighting both strengths and methodological concerns.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which outcomes showed benefit for cytoreductive surgery according to the letter?",{"text":68,"@type":64},"The letter notes significantly improved cancer-specific survival and overall survival for cytoreductive surgery compared with radiotherapy, while progression-free survival and CRPCFS showed no significant differences.",{"name":70,"@type":61,"acceptedAnswer":71},"What methodological issues does the letter raise about the meta-analysis?",{"text":72,"@type":64},"It questions accurate data extraction, unclear derivation of PFS and CRPCFS, potential incorrect sample-size extraction, the presence of negative hazard-ratio results in forest plots, and a misspelling of “radiotherapy” that could affect retrieval.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336615,1790167739,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":26,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":97,"preview_page_count":26,"preview_urls":144},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","’Correspondence  \nA commentary on ‘Assessment of treatment  \noutcomes: cytoreductive surgery compared to radiotherapy inoligometastatic prostate cancer–an in-depth quantitative evaluation and retrospective cohort analysis’  \nJiacheng Chen, MDa , Jincai Wu, MDa , Haijing Yu, MDb,*  \nDear Editor,  \nWe have read with great interest the study conducted by Chenget al. [1], which investigated the efﬁcacy of cytoreductive surgery compared to radiotherapy in managing patients with oligometastatic prostate cancer. In this study, the authors performed a pooled analysis comprising ﬁve studies involving 1425 patients and demonstrated that cytoreductive surgery was associated with signiﬁcantly improved cancer-speciﬁc survival and overall survival when compared to radiotherapy. However, there were no signiﬁcant differences observed between the two groups in terms of progression-free survival (PFS) and castration-resistant prostate cancer-free survival (CRPCFS) . The authors should be commended for providing up-to-date evidence supporting the superiority of cytoreductive surgery in oligometastatic prostate cancer management. Nevertheless, there are several concerns that require further clariﬁcation prior to the translation of these ﬁndings into clinical practice.  \nFirst, accurate data extraction is a fundamental prerequisite to ensure the reliability of meta-analysis results. Among the included studies, Patel et al.’s study[2] clearly reported both univariate and multivariate overall survival and cancer-speciﬁc survival outcomes between the two groups in its supplementary ﬁle. However, the data provided by this meta-analysis were pretty inconsistent with those of the primary study. Furthermore, upon careful examination of the original article, we discovered that Patel et al. [2] did not directly or indirectly report PFS and  \naDepartment of Hepatobiliary and Pancreatic Surgery, Hainan General Hospital (Hainan Afﬁliated Hospital of Hainan Medical University) and bDepartment of International Nursing School, Hainan Medical University, Haikou, Hainan Province, People’s Republic of China  \nJiacheng Chen and Jincai Wu share co-ﬁrst authorship.  \nSponsorships or competing interests that maybe relevant to content are disclosed atthe end of this article.  \n*Corresponding author. Address: Department of International Nursing School, Hainan Medical University, Haikou, Hainan Province 570102, People’s Republic of China. Tel.: +86 [18907569651. E-mail: yuhj0223@163.com](18907569651. E-mail: yuhj0223@163.com) (H. Yu).  \nCopyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0, which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms.  \nInternational Journal of Surgery (2024) 110:5161–5162  \nReceived 26 March 2024; Accepted 30 March 2024  \nPublished online 9 April 2024  \n[http://dx.doi.org/10.1097/JS9.0000000000001446](http://dx.doi.org/10.1097/JS9.0000000000001446)  \nCRPCFS. Further clariﬁcation is needed regarding whether the data included in this meta-analysis were obtained through communication with Patel and colleagues. Additionally, Cheng and colleagues erroneously extracted the sample size for cytoreductive surgery from Patel et al.’s study[2](176 patients are for radical prostatectomy ± external beam radiation therapy, not for radical prostatectomy alone) . Equally concerning, we found that Xue et al.’s study[3] did not report PFS between the two groups; it remains unclear how these authors extracted this particular data.  \nSecond, as a well-established statistical concept, the hazard ratio cannot be less than zero. However, we found that the statistical results of several forest plots in the present study were negative, such as Figures 2–1, 4, 5–1, and 5–2. The methodology employed in generating these","cbCaigoe6p9cUUVV","https://ap.wps.com/l/cbCaigoe6p9cUUVV","pdf",200349,"English","# Correspondence\n## Key commendations and overall assessment\n## Concerns requiring further clarification\n## Ethical approval and funding\n## Author contributions and conflicts of interest\n## Research registration\n## Provenance, peer review, acknowledgements\n## References","[{\"question\":\"What is the main purpose of this correspondence letter?\",\"answer\":\"To comment on a study comparing cytoreductive surgery with radiotherapy for oligometastatic prostate cancer, highlighting both strengths and methodological concerns.\"},{\"question\":\"Which outcomes showed benefit for cytoreductive surgery according to the letter?\",\"answer\":\"The letter notes significantly improved cancer-specific survival and overall survival for cytoreductive surgery compared with radiotherapy, while progression-free survival and CRPCFS showed no significant differences.\"},{\"question\":\"What methodological issues does the letter raise about the meta-analysis?\",\"answer\":\"It questions accurate data extraction, unclear derivation of PFS and CRPCFS, potential incorrect sample-size extraction, the presence of negative hazard-ratio results in forest plots, and a misspelling of “radiotherapy” that could affect retrieval.\"}]","Correspondence - A commentary on 'Assessment of treatment outcomes: cytoreductive surgery compared to radiotherapy in oligometastatic prostate cancer' | PDF",1790015870,[145,149],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2bd9ce734307915582483ff4c096e21c.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6028b26b3daafc2bcce63b18ce5c12c.webp",982,1309]